Explore how cognitive event-related potentials (ERPs) are transforming mental health diagnosis through objective brain wave biomarkers for conditions like schizophrenia, ADHD, and depression.
Comprehensive overview of recent advances in understanding the neurobiology of schizophrenia, including dopamine and glutamate hypotheses, protein network models, biomarkers, and treatment approaches.
Explore how biomarkers are transforming psychiatric diagnosis and treatment, offering objective biological data to complement traditional assessments.
Discover how late beta accentuation and N2 amplitude serve as biomarkers for psychosis risk across schizophrenia and bipolar disorder.
Exploring objective neurophysiological biomarkers for early detection and personalized treatment of psychosis spectrum disorders.